Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Jewell

Showing results (21-30 of 337) with videos related to

Pageof 34
Sort By:
Clinical Science (London, England : 1979)|February 1, 1990
Mechanism of action of 5-aminosalicylic acid and its derivativesA Ireland, D P Jewell
European Journal of Gastroenterology & Hepatology|February 1, 1996
Are cytokine gene polymorphisms important in the pathogenesis of inflammatory bowel disease?J Satsangi, D P Jewell
The Italian Journal of Gastroenterology|June 1, 1994
Response to treatment of microscopic colitisR Fasoli, D P Jewell
Scandinavian Journal of Gastroenterology|April 1, 1991
In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac diseaseG Mantzaris, D P Jewell
Scandinavian Journal of Gastroenterology|November 1, 1987
Olsalazine in patients intolerant of sulphasalazineA Ireland, D P Jewell
Alimentary Pharmacology & Therapeutics|April 1, 1989
Cyclosporin for the treatment of severe inflammatory bowel diseaseK Baker, D P Jewell
Gut|September 1, 1983
In vitro model for the assessment of luminal factors on rectal mucosaA Allan, D P Jewell
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1985
Immunology of inflammatory bowel diseaseD P Jewell, C Patel
Journal of Clinical Gastroenterology|December 1, 1989
Sulfasalazine-induced impotence: a beneficial resolution with olsalazine?A Ireland, D P Jewell
Alimentary Pharmacology & Therapeutics|May 1, 2001
Review article: the management of severe Crohn's diseaseM Parkes, D P Jewell
Pageof 34

Showing results (21-30 of 337) with videos related to

Sort By:
Pageof 34
Clinical Science (London, England : 1979)|February 1, 1990
Mechanism of action of 5-aminosalicylic acid and its derivativesA Ireland, D P Jewell
European Journal of Gastroenterology & Hepatology|February 1, 1996
Are cytokine gene polymorphisms important in the pathogenesis of inflammatory bowel disease?J Satsangi, D P Jewell
The Italian Journal of Gastroenterology|June 1, 1994
Response to treatment of microscopic colitisR Fasoli, D P Jewell
Scandinavian Journal of Gastroenterology|April 1, 1991
In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac diseaseG Mantzaris, D P Jewell
Scandinavian Journal of Gastroenterology|November 1, 1987
Olsalazine in patients intolerant of sulphasalazineA Ireland, D P Jewell
Alimentary Pharmacology & Therapeutics|April 1, 1989
Cyclosporin for the treatment of severe inflammatory bowel diseaseK Baker, D P Jewell
Gut|September 1, 1983
In vitro model for the assessment of luminal factors on rectal mucosaA Allan, D P Jewell
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1985
Immunology of inflammatory bowel diseaseD P Jewell, C Patel
Journal of Clinical Gastroenterology|December 1, 1989
Sulfasalazine-induced impotence: a beneficial resolution with olsalazine?A Ireland, D P Jewell
Alimentary Pharmacology & Therapeutics|May 1, 2001
Review article: the management of severe Crohn's diseaseM Parkes, D P Jewell
Pageof 34